Armistice Capital, LLC Solid Biosciences Inc. Transaction History

Armistice Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$7.19 - $32.37 $2.39 Million - $10.7 Million	-332,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$21.32 - $46.34 $3.58 Million - $7.79 Million	168,000 Added 102.44%	332,000 $8.9 Million
Q3 2018 Nov 14, 2018	SELL	$36.35 - $51.7 $581,600 - $827,200	-16,000 Reduced 8.89%	164,000 $7.74 Million
Q2 2018 Aug 14, 2018	BUY	$7.33 - $43.15 $1.32 Million - $7.77 Million	180,000 New	180,000 $6.41 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $56.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.